This site is intended for healthcare professionals
Drug news

FDA approves Argus II Retinal Prosthesis System for Retinitis Pigmentosa

Read time: 1 mins
Last updated:16th Feb 2013
Published:16th Feb 2013
Source: Pharmawand

The FDA on 14 February 2013 approved the Argus II Retinal Prosthesis System from Second Sight Medical Products Inc., the first implanted device to treat adult patients with advanced Retinitis Pigmentosa (RP). The device, which includes a small video camera, transmitter mounted on a pair of eyeglasses, video processing unit (VPU) and an implanted retinal prosthesis (artificial retina), replaces the function of degenerated cells in the retina (a membrane inside the eye) and may improve a patient�s ability to perceive images and movement. The VPU transforms images from the video camera into electronic data that is wirelessly transmitted to the retinal prosthesis.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.